Solid-organ transplants and the risks of pandemic influenza

The Lancet Infectious Diseases

Volumn 10, Issue 8, 2010, Pages 506-507

  Ljungman, Per ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GRAFT RECIPIENT; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; IMMUNOCOMPROMISED PATIENT; INFECTION RISK; INFLUENZA A (H1N1); INFLUENZA VACCINATION; INTENSIVE CARE UNIT; LETTER; MAJOR CLINICAL STUDY; ORGAN TRANSPLANTATION; PANDEMIC INFLUENZA; PNEUMONIA; PRIORITY JOURNAL; RISK ASSESSMENT; VIRUS STRAIN;

DISEASE OUTBREAKS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; ORGAN TRANSPLANTATION; RISK; VACCINATION;

EID: 77955095274     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(10)70136-5     Document Type: Letter

References (14)

1. Ljungman P, Ward KN, Crooks BN, et al. Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2001, 28:479-484.
2. Vilchez RA, McCurry K, Dauber J, et al. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2002, 2:287-291.
3. Nichols WG, Guthrie KA, Corey L, Boeckh M Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 2004, 39:1300-1306.
4. Machado CM, Boas LS, Mendes AV, et al. Use of oseltamivir to control influenza complications after bone marrow transplantation. Bone Marrow Transplant 2004, 34:111-114.
5. Ison MG, Sharma A, Shepard JA, Wain JC, Ginns LC Outcome of influenza infection managed with oseltamivir in lung transplant recipients. J Heart Lung Transplant 2008, 27:282-288.
6. Kumar D, Michaels MG, Morris MI, et al. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis 2010, published online July 9. 10.1016/S1473-3099(10)70133-X.
7. Ljungman P, Cordonnier C, Einsele H, et al. Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant 2009, 44:521-526.
8. Fiore AE, Shay DK, Broder K, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009, 58:1-52.
9. Berben L, Denhaerynck K, Schaub S, De Geest S Prevalence and correlates of influenza vaccination among kidney transplant patients. Prog Transplant 2009, 19:312-317.
10. Harris K, Baggs J, Davis RL, et al. Influenza vaccination coverage among adult solid organ transplant recipients at three health maintenance organizations, 1995-2005. Vaccine 2009, 27:2335-2341.
11. Machado CM, Cardoso MR, da Rocha IF, Boas LS, Dulley FL, Pannuti CS The benefit of influenza vaccination after bone marrow transplantation. Bone Marrow Transplant 2005, 36:897-900.
12. Pauksen K, Linde A, Hammarstrom V, et al. Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients. Clin Infect Dis 2000, 30:342-348.
13. Burbach G, Bienzle U, Stark K, et al. Influenza vaccination in liver transplant recipients. Transplantation 1999, 67:753-755.
14. Blumberg EA, Fitzpatrick J, Stutman PC, Hayden FG, Brozena SC Safety of influenza vaccine in heart transplant recipients. J Heart Lung Transplant 1998, 17:1075-1080.